Postpartum depression pill gets approval in a 1st for Canada – National
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is...
Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name Zurzuvae, is...
The birth of a child is an exciting yet potentially overwhelming experience, often accompanied by feelings of burden, worry, sadness,...
Chen Q, Li W, Xiong J, Zheng X. Prevalence and risk factors associated with postpartum depression during the COVID-19 pandemic:...
American College of Obstetricians and Gynecologists. Physical activity and exercise during pregnancy and the postpartum period: ACOG committee opinion, number...
Depression was predicted to rank as the second most prevalent cause of disability globally in 2023 . A kind of...
In Latvia, 18% of new mothers suffer from postpartum depression, a rate higher than in other European countries, according to...
Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks...
Despite growing conversations around mental health, maternal mental health, particularly postpartum depression, continues to be a blind spot in our...
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and the social enterprise Breathe...